Scientific Overview: 2013 BBC Plenary Symposium on Tobacco Addiction

Overview

Journal Drug Alcohol Depend

Publisher Elsevier

Specialty Psychiatry

Date 2014 Jun 18

PMID 24934691

Citations 6

Authors

M De Biasi

I McLaughlin

E E Perez

P A Crooks

L P Dwoskin

M T Bardo

P R Pentel

D Hatsukami

Affiliations

Soon will be listed here.

Abstract

Nicotine dependence plays a critical role in addiction to tobacco products, and thus contributes to a variety of devastating tobacco-related diseases (SGR 2014). Annual costs associated with smoking in the US are estimated to be between $289 and $333 billion. Effective interventions for nicotine dependence, especially in smokers, are a critical barrier to the eradication of tobacco-related diseases. This overview highlights research presented at the Plenary Symposium of Behavior, Biology and Chemistry: Translational Research in Addiction Conference (BBC), hosted by the UT Health Science Center San Antonio, on March 9-10, 2013. The Plenary Symposium focused on tobacco addiction, and covered topics ranging from basic science to national policy. As in previous years, the meeting brought together globally-renowned scientists, graduate student recruits, and young scientists from underrepresented populations in Texas and other states with the goal of fostering interest in drug addiction research in young generations.

Citing Articles

Psychoactive Comfort Products or Snacks: How Chinese Young Adults Perceive the Potentially Addictive Nature of E-Cigarettes.

Song A, Zhang Z, Liu Z Healthcare (Basel). 2023; 11(10).

PMID: 37239726 PMC: 10218233. DOI: 10.3390/healthcare11101440.

The medial habenula and interpeduncular nucleus circuitry is critical in addiction, anxiety, and mood regulation.

McLaughlin I, Dani J, De Biasi M J Neurochem. 2017; 142 Suppl 2:130-143.

PMID: 28791703 PMC: 6740332. DOI: 10.1111/jnc.14008.

Rationalization of a nanoparticle-based nicotine nanovaccine as an effective next-generation nicotine vaccine: A focus on hapten localization.

Zhao Z, Hu Y, Harmon T, Pentel P, Ehrich M, Zhang C Biomaterials. 2017; 138:46-56.

PMID: 28551462 PMC: 5544940. DOI: 10.1016/j.biomaterials.2017.05.031.

Engineering of a hybrid nanoparticle-based nicotine nanovaccine as a next-generation immunotherapeutic strategy against nicotine addiction: A focus on hapten density.

Zhao Z, Powers K, Hu Y, Raleigh M, Pentel P, Zhang C Biomaterials. 2017; 123:107-117.

PMID: 28167389 PMC: 5344186. DOI: 10.1016/j.biomaterials.2017.01.038.

Nicotinic Acetylcholine Receptors as Targets for Tobacco Cessation Therapeutics: Cutting-Edge Methodologies to Understand Receptor Assembly and Trafficking.

Fox-Loe A, Dwoskin L, Richards C Neuromethods. 2016; 117:119-132.

PMID: 28025590 PMC: 5180357. DOI: 10.1007/978-1-4939-3768-4_7.

References

Dani J, Bertrand D . Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol. 2006; 47:699-729. DOI: 10.1146/annurev.pharmtox.47.120505.105214. View

Carrera M, Ashley J, Hoffman T, Isomura S, Wirsching P, Koob G . Investigations using immunization to attenuate the psychoactive effects of nicotine. Bioorg Med Chem. 2004; 12(3):563-70. DOI: 10.1016/j.bmc.2003.11.029. View

de Villiers S, Cornish K, Troska A, Pravetoni M, Pentel P . Increased efficacy of a trivalent nicotine vaccine compared to a dose-matched monovalent vaccine when formulated with alum. Vaccine. 2013; 31(52):6185-93. PMC: 4019346. DOI: 10.1016/j.vaccine.2013.10.051. View

Lindblom N, de Villiers S, Kalayanov G, Gordon S, Johansson A, Svensson T . Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats. Respiration. 2002; 69(3):254-60. DOI: 10.1159/000063629. View

Thorgeirsson T, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson K . A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008; 452(7187):638-642. PMC: 4539558. DOI: 10.1038/nature06846. View

Isomura S, Wirsching P, Janda K . An immunotherapeutic program for the treatment of nicotine addiction: hapten design and synthesis. J Org Chem. 2001; 66(12):4115-21. DOI: 10.1021/jo001442w. View

De B, Pagovich O, Hicks M, Rosenberg J, Moreno A, Janda K . Disrupted adenovirus-based vaccines against small addictive molecules circumvent anti-adenovirus immunity. Hum Gene Ther. 2012; 24(1):58-66. PMC: 3555097. DOI: 10.1089/hum.2012.163. View

Dwoskin L, Smith A, Wooters T, Zhang Z, Crooks P, Bardo M . Nicotinic receptor-based therapeutics and candidates for smoking cessation. Biochem Pharmacol. 2009; 78(7):732-43. PMC: 4110684. DOI: 10.1016/j.bcp.2009.06.002. View

Li M, Cheng R, Ma J, Swan G . A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction. 2002; 98(1):23-31. DOI: 10.1046/j.1360-0443.2003.00295.x. View

10.

Salas R, Pieri F, De Biasi M . Decreased signs of nicotine withdrawal in mice null for the beta4 nicotinic acetylcholine receptor subunit. J Neurosci. 2004; 24(45):10035-9. PMC: 6730195. DOI: 10.1523/JNEUROSCI.1939-04.2004. View

11.

Benowitz N, Henningfield J . Establishing a nicotine threshold for addiction. The implications for tobacco regulation. N Engl J Med. 1994; 331(2):123-5. DOI: 10.1056/NEJM199407143310212. View

12.

Pravetoni M, Keyler D, Pidaparthi R, Carroll F, Runyon S, Murtaugh M . Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities. Biochem Pharmacol. 2011; 83(4):543-50. PMC: 3259188. DOI: 10.1016/j.bcp.2011.11.004. View

13.

McHeyzer-Williams L, McHeyzer-Williams M . Antigen-specific memory B cell development. Annu Rev Immunol. 2005; 23:487-513. DOI: 10.1146/annurev.immunol.23.021704.115732. View

14.

Albayati Z, Dwoskin L, Crooks P . Pharmacokinetics of the novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide in the rat. Drug Metab Dispos. 2008; 36(10):2024-9. PMC: 3652806. DOI: 10.1124/dmd.108.020354. View

15.

Fowler C, Kenny P . Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability. Neuropharmacology. 2013; 76 Pt B:533-44. PMC: 3858456. DOI: 10.1016/j.neuropharm.2013.09.008. View

16.

Satoskar S, Keyler D, Lesage M, Raphael D, Ross C, Pentel P . Tissue-dependent effects of immunization with a nicotine conjugate vaccine on the distribution of nicotine in rats. Int Immunopharmacol. 2003; 3(7):957-70. DOI: 10.1016/S1567-5769(03)00094-8. View

17.

Hung R, McKay J, Gaborieau V, Boffetta P, Hashibe M, Zaridze D . A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature. 2008; 452(7187):633-7. DOI: 10.1038/nature06885. View

18.

Grebenstein P, Burroughs D, Zhang Y, Lesage M . Sex differences in nicotine self-administration in rats during progressive unit dose reduction: implications for nicotine regulation policy. Pharmacol Biochem Behav. 2013; 114-115:70-81. PMC: 3903094. DOI: 10.1016/j.pbb.2013.10.020. View

19.

. Quitting smoking among adults--United States, 2001-2010. MMWR Morb Mortal Wkly Rep. 2011; 60(44):1513-9. View

20.

Wang J, Grucza R, Cruchaga C, Hinrichs A, Bertelsen S, Budde J . Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence. Mol Psychiatry. 2008; 14(5):501-10. PMC: 4381434. DOI: 10.1038/mp.2008.42. View